| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3440315 | American Journal of Obstetrics and Gynecology | 2007 | 11 Pages |
Abstract
GPR30 represents an alternative estrogen-responsive receptor that is overexpressed in tumors where estrogen and progesterone receptors are downregulated, and in high-risk endometrial cancer patients with lower survival rates.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Harriet O. MD, Kimberly K. MD, Meenakshi MD, Clifford R. PhD, Chetana M. PhD, Nancy E. MD, Eric R. PhD,